GSK-2018682
Product Detail
Khoom cim npe
| Pob Loj | Muaj | Nqe (USD) |
Lub npe tshuaj:
4-(4-(5-(5-chloro-6-isopropoxypyridin-3-yl)-1,2,4-oxadiazol-3-yl)-1H-indol-1-yl)butanoic acid
SMILES Code:
O=C(O)CCCN1C=CC2=C1C=CC=C2C3=NOC(C4=CC(Cl)=C(OC(C)C)N=C4)=N3
InChi Code:
InChI = 1S/C22H21ClN4O4/c1-13(2)30-22-17(23)11-14(12-24-22)21-25-20(26-31-21)16-5-3-6- 18-15(16)8-10-27(18)9-4-7-19(28)29/h3,5-6,8,10-13H,4,7,9H2,1-2H3,(H , 28, 29) ib.
InChi Key:
NFIGDBFIDKDNIG-UHFFFAOYSA-N
Lo lus tseem ceeb:
1034688-30-6; CAS: 1034688-30-6; CAS: 1034688-30-6; GSK-2018682; GSK 2018682; GSK2018682; 2018682 ua
Solubility:Soluble hauv DMSO
Cia:0 - 4 C rau lub sijhawm luv (hnub mus rau lub lis piam), lossis -20 C rau lub sijhawm ntev (hli).
Nqe lus piav qhia:
GSK2018682 yog agonist rau S1P1 thiab S1P5 receptors.
Lub Hom Phiaj: Agonists rau S1P1 thiab S1P5 txais
![(S)-2-(4-(4-(4-(5-(1-amino-1-(4-fluorophenyl)ethyl)pyrimidin-2-yl)piperazin-1-yl)pyrrolo[2,1- f [1,2,4]triazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol](http://www.caerulumpharm.com/uploads/微信截图_20220802163212-300x280.png)
